Literature DB >> 31640

Drug variables in the etiology of tardive dyskinesia application of discriminant function analysis.

G Gardos, J O Cole, R A La Brie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 31640     DOI： 10.1016/0364-7722(77)90037-6

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol        ISSN： 0364-7722


× No keyword cloud information.
  7 in total

1.  Tardive dyskinesia during and following treatment with haloperidol, haloperidol + biperiden, thioridazine, and clozapine.

Authors:  J Gerlach; H Simmelsgaard
Journal:  Psychopharmacology (Berl)       Date:  1978-10-31       Impact factor: 4.530

2.  Topographic subtypes of tardive dyskinesia in schizophrenic patients aged less than 60 years: relationship to demographic, clinical, treatment, and neuropsychological variables.

Authors:  O Gureje
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-12       Impact factor: 10.154

3.  Tardive dyskinesia and psychotropic drug history.

Authors:  G M Simpson; E Varga; J H Lee; B Zoubok
Journal:  Psychopharmacology (Berl)       Date:  1978-07-06       Impact factor: 4.530

4.  A monitoring test for the liability of neuroleptic drugs to induce tardive dyskinesia.

Authors:  L M Gunne; S Bárány
Journal:  Psychopharmacology (Berl)       Date:  1979-06-21       Impact factor: 4.530

5.  Serum neuroleptic activity, prolactin, and tardive dyskinesia in schizophrenic outpatients.

Authors:  J G Csernansky; J Kaplan; C A Holman; L E Hollister
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

Review 6.  Long-term depot antipsychotics. A risk-benefit assessment.

Authors:  T R Barnes; D A Curson
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

7.  Absence of severe tardive dyskinesia in Hungarian schizophrenic out-patients.

Authors:  G Gardos; I Samu; M Kallos; J O Cole
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.